Maria Carmen Rita Gonzales Vigilar
Child & Adolescent Psychiatry · Ashburn, VANPI 1649217571
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 340 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 340 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Otsuka America Pharmaceutical, Inc.$892
- Ironshore Pharmaceuticals Inc.$845
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$697
- Corium, LLC$567
- Tris Pharma Inc$527
- plus $2K from 13 others
What the payments were for
- Food & beverage$6,355100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 66 | $1,171 |
| Otsuka America Pharmaceutical, Inc. | 54 | $892 |
| Ironshore Pharmaceuticals Inc. | 45 | $845 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $697 |
| Corium, LLC | 27 | $567 |
| Tris Pharma Inc | 28 | $527 |
| Axsome Therapeutics, Inc. | 20 | $511 |
| Lundbeck LLC | 25 | $470 |
| Vertical Pharmaceuticals, LLC | 10 | $177 |
| Collegium Pharmaceutical, Inc. | 12 | $167 |
| Shire North American Group Inc | 6 | $84 |
| Supernus Pharmaceuticals, Inc. | 4 | $70 |
| Adlon Therapeutics L.p. | 4 | $58 |
| Johnson & Johnson | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Neos Therapeutics, LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$121
How this compares
$6,355 in reported general payments places this provider in the 95th percentile of 115 child & adolescent psychiatry providers in Virginia.
See all child & adolescent psychiatry providers in Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 24 | $1,093 |
| Alprazolam | 21 | $184 |
| Benztropine Mesylate | 12 | $161 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Ashburn
- Charles HallRichmond$10K
- Chandramouleswar AmaraPetersburg$10K
- David GouldRichmond$9K
- Rakesh ShahHopewell$7K
- Vikas MangewalaFairfax$7K
- Stacy PaggiFairfax$6K
- Craig SwaineyRichmond$5K
- Hemalatha MukharaManassas$4K
- Temitope OyegbileMc Lean$4K
- Ali AltahirStafford$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.